FOCUSED ASSAY
IFN-1 Test
Measure interferon pathway activity to identify SLE patients more likely to experience moderate to severe disease.
Contact Us
Type 1Interferon results
DxTerity's IFN-1 Test uses a simple fingerstick blood collection conducted at your doctor's office. Measure your IFN-1 levels and know your risks for SLE disease progression.
Multiple RNA measurements
Indication of SLE disease severity
Changes in IFN-1 Level
The DxTerity IFN-1 Test was developed and validated by DxTerity’s CAP-accredited, CLIA-certified laboratory. This test has not been cleared or approved by the U.S. Food and Drug Administration.
CLINICAL EVIDENCE
What the Type 1 Interferon (IFN-1) research shows
>50%
of SLE patients show elevated IFN-1 expression
IFN-1 High
strong correlation to more severe disease
12
published peer-reviewed studies
Precision medicine for autoimmune disease
DxTerity is at the forefront of diagnostic test innovation, addressing the unmet need of those suffering from immune-mediated disease. We are dedicated to using the latest technologies and advancements to deliver clinically relevant, precision diagnostic tools to help healthcare providers improve patient outcomes. Unlike precision medicine for cancer which primarily relies on DNA mutation testing, autoimmune disease looks at RNA, because its dynamic nature provides insight into biological pathway activity that drives disease.
A therapeutic evolution
New treatments target the biological pathways that drive the development of autoimmune disease. Examples include therapies which block Type-1 Interferon signaling, monoclonal antibodies targeting the B-Cell Activating Factor (BAFF) and its cellular receptor, or CAR-T cellular therapeutics which look to faciliate total iimmune system reset and disease cure..
Type 1 Interferon (IFN-1)
Scientific literature has shown IFN-1 activity levels may provide information to help guide treatment decisions. IFN-1 High patients show increased risk of developing severe disease, and decreased likelihood of responding to standard of care. Patients with higher IFN-1 levels have been shown to have an increased response to IFN-1 targeted therapeutic pathways.
Resources & downloads
Eular IFN-1 Poster
Test performance and analytical validation data.
Download PDF →
Publications
Helpful Lupus Educational Resources
Download PDF
Test Requisition Form
Forms and instructions for ordering access.
Download PDF →
Test Report Example
Laboratory Report Example
Download PDF →
Experience Simplicity
“The ease of testing from the physicians office is a real difference maker.”
Lupus Patient
Contact us about testing for IFN-1
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.
FOCUSED ASSAY
IFN-1 Test
Measure interferon pathway activity to identify SLE patients more likely to experience moderate to severe disease.
Contact us
Type 1Interferon results
DxTerity's IFN-1 Test uses a simple fingerstick blood collection conducted at your doctor's office. Measure your IFN-1 levels and know your risks for SLE disease progression.
Multiple RNA measurements
Measures 4 messenger RNAs (mRNAs) associated with Type 1 Interferon (IFN-1) activity.
Indication of SLE disease severity
Prognostic markers for increased risk of moderate to severe Systemic Lupus Erythematous (SLE) .
Changes in IFN-1 Level
Identify changes in IFN-1 levels
Patient Result Graph
-4
-3
-2
-1
0
1
2
3
4
Date:
MM
DD
YY
Date:
MM
DD
YY
Date:
MM
DD
YY
Date:
MM
DD
YY
Physician Requisition
The DxTerity IFN-1 Test was developed and validated by DxTerity’s CAP-accredited, CLIA-certified laboratory. This test has not been cleared or approved by the U.S. Food and Drug Administration.
CLINICAL EVIDENCE
What the Type 1 Interferon (IFN-1) research shows
>50%
of SLE patients show elevated IFN-1 expression
IFN-1 High
strong correlation to more severe disease
12
published peer-reviewed studies
Precision medicine for autoimmune disease
DxTerity is at the forefront of diagnostic test innovation, addressing the unmet need of those suffering from immune-mediated disease. We are dedicated to using the latest technologies and advancements to deliver clinically relevant, precision diagnostic tools to help healthcare providers improve patient outcomes. Unlike precision medicine for cancer which primarily relies on DNA mutation testing, autoimmune disease looks at RNA, because its dynamic nature provides insight into biological pathway activity that drives disease.
A therapeutic evolution
New treatments target the biological pathways that drive the development of autoimmune disease. Examples include therapies which block Type-1 Interferon signaling, monoclonal antibodies targeting the B-Cell Activating Factor (BAFF) and its cellular receptor, or CAR-T cellular therapeutics which look to facilitate total immune system reset and disease cure..
Type 1 Interferon (IFN-1)
Scientific literature has shown IFN-1 activity levels may provide information to help guide treatment decisions. IFN-1 High patients show increased risk of developing severe disease, and decreased likelihood of responding to standard of care. Patients with higher IFN-1 levels have been shown to have an increased response to IFN-1 targeted therapeutic pathways.
Resources & downloads
Eular IFN-1 Poster
Test performance and analytical validation data.
Download PDF →
Publications
Helpful Lupus Educational Resources
Download PDF →
Test Requisition Form
Forms and instructions for ordering access.
Download PDF →
Test Report Example
Laboratory Report Example
Download PDF →
Experience Simplicity
“The ease of testing from the physicians office is a real difference maker.”
Lupus Patient
Contact us about testing for IFN-1
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.